Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Open Forum Infectious Diseases|November 2, 2020
Management of Gram-Negative Bloodstream Infections in the Era of Rapid Diagnostic Testing: Impact With and Without Antibiotic StewardshipKimberly C Claeys, Emily L Heil, Stephanie Hitchcock, et al.
Diagnostic Microbiology and Infectious Disease|August 2, 2021
The potential impact of discrepancies between automated susceptibility platforms and other testing metho`dologies for cefazolin in the treatment of Enterobacterales bloodstream infectionsMandee Noval, Emily L Heil, Paula Williams, et al.
Open Forum Infectious Diseases|June 22, 2026
Recalibration and Validation of a Risk Scoring Tool to Predict Multidrug-Resistant Pseudomonas aeruginosaNhu Le, Hyunuk Seung, Megan E Dunning, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2025
The Effectiveness of Newer Beta-Lactams for the Treatment of Antimicrobial-Resistant Gram-Negative MeningitisAlice J Hsu, Kathleen Chiotos, Emily L Heil, et al.
Open Forum Infectious Diseases|July 25, 2022
Real-world Antimicrobial Stewardship Experience in a Large Academic Medical Center: Using Statistical and Machine Learning Approaches to Identify Intervention "Hotspots" in an Antibiotic Audit and Feedback ProgramKatherine E Goodman, Emily L Heil, Kimberly C Claeys, et al.
Antiviral Therapy|September 8, 2018
Effectiveness of 8 weeks of ledipasvir/sofosbuvir for hepatitis C in HCV-HIV-coinfected patientsAna D Vega, Lauren M Hynicka, Kimberly Claeys, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2018
Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill PatientsEmily L Heil, David P Nicolau, Andras Farkas, et al.
BMJ Open Quality|July 25, 2024
Impact of the US Food and Drug Administration warning regarding increased risk of aortic aneurysms or aortic dissections on fluoroquinolone prescribing trendsJohn G Rizk, Julia F Slejko, Emily L Heil, et al.
Antibiotics (Basel, Switzerland)|June 18, 2020
Rifabutin Use in Staphylococcus Biofilm Infections: A Case SeriesJames B Doub, Emily L Heil, Afua Ntem-Mensah, et al.
Open Forum Infectious Diseases|October 30, 2023
Crossroads of Antimicrobial and Diagnostic Stewardship: Assessing Risks to Develop Clinical Decision Support to Combat Multidrug-Resistant PseudomonasIris Zou, Daniel Abate, Michelle Newman, et al.
Pageof 12